The Mistletoe and Breast Cancer (MAB) Study: A UK Mixed-Phase, Pilot, Placebo-Controlled, Double-Blind, Randomised Controlled Trial
This pilot study examined the feasibility of conducting a randomised placebo-controlled, double-blind trial of mistletoe therapy for breast cancer patients within the UK NHS. The results describe the challenges and achievements of recruitment, retention, adherence, blinding, and safety in this context.
Authors
- Maria Gresham
- Lorna Duncan (ORCID: https://orcid.org/0000-0002-9629-030X)
- Alyson Huntley (ORCID: https://orcid.org/0000-0001-9409-7891)
- PaulC. Gibson
- Debbie Sharp (ORCID: https://orcid.org/0000-0003-3071-9860)
- Jeremy Braybrooke (ORCID: https://orcid.org/0000-0003-1943-7360)
- Susan Bryant
- Gene Solomon Feder (ORCID: https://orcid.org/0000-0002-7890-3926)
Institutions
- University Hospitals Bristol NHS Foundation Trust (GB)
- University of Bristol (GB)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3390/cancers17193169
- Primary Topic
- Toxin Mechanisms and Immunotoxins
- Type
- article
- Field-Weighted Citation Impact
- 0.00